Global Quadrivalent Flu Vaccine Market Growth 2025-2031

December 2025 | 81 pages | ID: G12E6591F82DEN
LP Information

Abstracts

The global Quadrivalent Flu Vaccine market size is predicted to grow from US$ 5992 million in 2025 to US$ 8408 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Quadrivalent Flu Vaccine Industry Forecast” looks at past sales and reviews total world Quadrivalent Flu Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Quadrivalent Flu Vaccine sales for 2025 through 2031. With Quadrivalent Flu Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quadrivalent Flu Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Quadrivalent Flu Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quadrivalent Flu Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quadrivalent Flu Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quadrivalent Flu Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quadrivalent Flu Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Quadrivalent Flu Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Intramuscular Injection
• Nasal Spray
• Intradermal Shot

Segmentation by Application:

• Hospital
• Clinic
• Public Health Agency
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi Pasteur
• AstraZeneca
• CSL
• Abbott
• GlaxoSmithKline

Key Questions Addressed in this Report

What is the 10-year outlook for the global Quadrivalent Flu Vaccine market?

What factors are driving Quadrivalent Flu Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Quadrivalent Flu Vaccine market opportunities vary by end market size?

How does Quadrivalent Flu Vaccine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Quadrivalent Flu Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Quadrivalent Flu Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Quadrivalent Flu Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Quadrivalent Flu Vaccine Segment by Type
  2.2.1 Intramuscular Injection
  2.2.2 Nasal Spray
  2.2.3 Intradermal Shot
2.3 Quadrivalent Flu Vaccine Sales by Type
  2.3.1 Global Quadrivalent Flu Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global Quadrivalent Flu Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Quadrivalent Flu Vaccine Sale Price by Type (2020-2025)
2.4 Quadrivalent Flu Vaccine Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Public Health Agency
  2.4.4 Other
2.5 Quadrivalent Flu Vaccine Sales by Application
  2.5.1 Global Quadrivalent Flu Vaccine Sale Market Share by Application (2020-2025)
  2.5.2 Global Quadrivalent Flu Vaccine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Quadrivalent Flu Vaccine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Quadrivalent Flu Vaccine Breakdown Data by Company
  3.1.1 Global Quadrivalent Flu Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global Quadrivalent Flu Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Quadrivalent Flu Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global Quadrivalent Flu Vaccine Revenue by Company (2020-2025)
  3.2.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Quadrivalent Flu Vaccine Sale Price by Company
3.4 Key Manufacturers Quadrivalent Flu Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Quadrivalent Flu Vaccine Product Location Distribution
  3.4.2 Players Quadrivalent Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR QUADRIVALENT FLU VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Quadrivalent Flu Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Quadrivalent Flu Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Quadrivalent Flu Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Quadrivalent Flu Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global Quadrivalent Flu Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Quadrivalent Flu Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Quadrivalent Flu Vaccine Sales Growth
4.4 APAC Quadrivalent Flu Vaccine Sales Growth
4.5 Europe Quadrivalent Flu Vaccine Sales Growth
4.6 Middle East & Africa Quadrivalent Flu Vaccine Sales Growth

5 AMERICAS

5.1 Americas Quadrivalent Flu Vaccine Sales by Country
  5.1.1 Americas Quadrivalent Flu Vaccine Sales by Country (2020-2025)
  5.1.2 Americas Quadrivalent Flu Vaccine Revenue by Country (2020-2025)
5.2 Americas Quadrivalent Flu Vaccine Sales by Type (2020-2025)
5.3 Americas Quadrivalent Flu Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Quadrivalent Flu Vaccine Sales by Region
  6.1.1 APAC Quadrivalent Flu Vaccine Sales by Region (2020-2025)
  6.1.2 APAC Quadrivalent Flu Vaccine Revenue by Region (2020-2025)
6.2 APAC Quadrivalent Flu Vaccine Sales by Type (2020-2025)
6.3 APAC Quadrivalent Flu Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Quadrivalent Flu Vaccine by Country
  7.1.1 Europe Quadrivalent Flu Vaccine Sales by Country (2020-2025)
  7.1.2 Europe Quadrivalent Flu Vaccine Revenue by Country (2020-2025)
7.2 Europe Quadrivalent Flu Vaccine Sales by Type (2020-2025)
7.3 Europe Quadrivalent Flu Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Quadrivalent Flu Vaccine by Country
  8.1.1 Middle East & Africa Quadrivalent Flu Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quadrivalent Flu Vaccine
10.3 Manufacturing Process Analysis of Quadrivalent Flu Vaccine
10.4 Industry Chain Structure of Quadrivalent Flu Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Quadrivalent Flu Vaccine Distributors
11.3 Quadrivalent Flu Vaccine Customer

12 WORLD FORECAST REVIEW FOR QUADRIVALENT FLU VACCINE BY GEOGRAPHIC REGION

12.1 Global Quadrivalent Flu Vaccine Market Size Forecast by Region
  12.1.1 Global Quadrivalent Flu Vaccine Forecast by Region (2026-2031)
  12.1.2 Global Quadrivalent Flu Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Quadrivalent Flu Vaccine Forecast by Type (2026-2031)
12.7 Global Quadrivalent Flu Vaccine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi Pasteur
  13.1.1 Sanofi Pasteur Company Information
  13.1.2 Sanofi Pasteur Quadrivalent Flu Vaccine Product Portfolios and Specifications
  13.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Pasteur Main Business Overview
  13.1.5 Sanofi Pasteur Latest Developments
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Information
  13.2.2 AstraZeneca Quadrivalent Flu Vaccine Product Portfolios and Specifications
  13.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AstraZeneca Main Business Overview
  13.2.5 AstraZeneca Latest Developments
13.3 CSL
  13.3.1 CSL Company Information
  13.3.2 CSL Quadrivalent Flu Vaccine Product Portfolios and Specifications
  13.3.3 CSL Quadrivalent Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 CSL Main Business Overview
  13.3.5 CSL Latest Developments
13.4 Abbott
  13.4.1 Abbott Company Information
  13.4.2 Abbott Quadrivalent Flu Vaccine Product Portfolios and Specifications
  13.4.3 Abbott Quadrivalent Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Abbott Main Business Overview
  13.4.5 Abbott Latest Developments
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Information
  13.5.2 GlaxoSmithKline Quadrivalent Flu Vaccine Product Portfolios and Specifications
  13.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 GlaxoSmithKline Main Business Overview
  13.5.5 GlaxoSmithKline Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Quadrivalent Flu Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Quadrivalent Flu Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Intramuscular Injection
Table 4. Major Players of Nasal Spray
Table 5. Major Players of Intradermal Shot
Table 6. Global Quadrivalent Flu Vaccine Sales by Type (2020-2025) & (K Doses)
Table 7. Global Quadrivalent Flu Vaccine Sales Market Share by Type (2020-2025)
Table 8. Global Quadrivalent Flu Vaccine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2020-2025)
Table 10. Global Quadrivalent Flu Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 11. Global Quadrivalent Flu Vaccine Sale by Application (2020-2025) & (K Doses)
Table 12. Global Quadrivalent Flu Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Quadrivalent Flu Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Quadrivalent Flu Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Quadrivalent Flu Vaccine Sales by Company (2020-2025) & (K Doses)
Table 17. Global Quadrivalent Flu Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Quadrivalent Flu Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Quadrivalent Flu Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Quadrivalent Flu Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Quadrivalent Flu Vaccine Producing Area Distribution and Sales Area
Table 22. Players Quadrivalent Flu Vaccine Products Offered
Table 23. Quadrivalent Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Quadrivalent Flu Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Quadrivalent Flu Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Quadrivalent Flu Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Quadrivalent Flu Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Quadrivalent Flu Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Quadrivalent Flu Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Quadrivalent Flu Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Quadrivalent Flu Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Quadrivalent Flu Vaccine Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Quadrivalent Flu Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Quadrivalent Flu Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Quadrivalent Flu Vaccine Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Quadrivalent Flu Vaccine Sales by Application (2020-2025) & (K Doses)
Table 39. APAC Quadrivalent Flu Vaccine Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Quadrivalent Flu Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Quadrivalent Flu Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Quadrivalent Flu Vaccine Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Quadrivalent Flu Vaccine Sales by Application (2020-2025) & (K Doses)
Table 44. Europe Quadrivalent Flu Vaccine Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Quadrivalent Flu Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Quadrivalent Flu Vaccine Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Quadrivalent Flu Vaccine Sales by Application (2020-2025) & (K Doses)
Table 48. Middle East & Africa Quadrivalent Flu Vaccine Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Quadrivalent Flu Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Quadrivalent Flu Vaccine
Table 53. Key Market Challenges & Risks of Quadrivalent Flu Vaccine
Table 54. Key Industry Trends of Quadrivalent Flu Vaccine
Table 55. Quadrivalent Flu Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Quadrivalent Flu Vaccine Distributors List
Table 58. Quadrivalent Flu Vaccine Customer List
Table 59. Global Quadrivalent Flu Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Quadrivalent Flu Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Quadrivalent Flu Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Quadrivalent Flu Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Quadrivalent Flu Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Quadrivalent Flu Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Quadrivalent Flu Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Quadrivalent Flu Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Quadrivalent Flu Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Quadrivalent Flu Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Quadrivalent Flu Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Quadrivalent Flu Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Quadrivalent Flu Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 72. Global Quadrivalent Flu Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Sanofi Pasteur Basic Information, Quadrivalent Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Pasteur Quadrivalent Flu Vaccine Product Portfolios and Specifications
Table 75. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. Sanofi Pasteur Main Business
Table 77. Sanofi Pasteur Latest Developments
Table 78. AstraZeneca Basic Information, Quadrivalent Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. AstraZeneca Quadrivalent Flu Vaccine Product Portfolios and Specifications
Table 80. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. CSL Basic Information, Quadrivalent Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Quadrivalent Flu Vaccine Product Portfolios and Specifications
Table 85. CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. Abbott Basic Information, Quadrivalent Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Quadrivalent Flu Vaccine Product Portfolios and Specifications
Table 90. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. GlaxoSmithKline Basic Information, Quadrivalent Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Quadrivalent Flu Vaccine Product Portfolios and Specifications
Table 95. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Quadrivalent Flu Vaccine
Figure 2. Quadrivalent Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quadrivalent Flu Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Quadrivalent Flu Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Quadrivalent Flu Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Quadrivalent Flu Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Quadrivalent Flu Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Intramuscular Injection
Figure 12. Product Picture of Nasal Spray
Figure 13. Product Picture of Intradermal Shot
Figure 14. Global Quadrivalent Flu Vaccine Sales Market Share by Type in 2025
Figure 15. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2020-2025)
Figure 16. Quadrivalent Flu Vaccine Consumed in Hospital
Figure 17. Global Quadrivalent Flu Vaccine Market: Hospital (2020-2025) & (K Doses)
Figure 18. Quadrivalent Flu Vaccine Consumed in Clinic
Figure 19. Global Quadrivalent Flu Vaccine Market: Clinic (2020-2025) & (K Doses)
Figure 20. Quadrivalent Flu Vaccine Consumed in Public Health Agency
Figure 21. Global Quadrivalent Flu Vaccine Market: Public Health Agency (2020-2025) & (K Doses)
Figure 22. Quadrivalent Flu Vaccine Consumed in Other
Figure 23. Global Quadrivalent Flu Vaccine Market: Other (2020-2025) & (K Doses)
Figure 24. Global Quadrivalent Flu Vaccine Sale Market Share by Application (2024)
Figure 25. Global Quadrivalent Flu Vaccine Revenue Market Share by Application in 2025
Figure 26. Quadrivalent Flu Vaccine Sales by Company in 2025 (K Doses)
Figure 27. Global Quadrivalent Flu Vaccine Sales Market Share by Company in 2025
Figure 28. Quadrivalent Flu Vaccine Revenue by Company in 2025 ($ millions)
Figure 29. Global Quadrivalent Flu Vaccine Revenue Market Share by Company in 2025
Figure 30. Global Quadrivalent Flu Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Quadrivalent Flu Vaccine Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Quadrivalent Flu Vaccine Sales 2020-2025 (K Doses)
Figure 33. Americas Quadrivalent Flu Vaccine Revenue 2020-2025 ($ millions)
Figure 34. APAC Quadrivalent Flu Vaccine Sales 2020-2025 (K Doses)
Figure 35. APAC Quadrivalent Flu Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Europe Quadrivalent Flu Vaccine Sales 2020-2025 (K Doses)
Figure 37. Europe Quadrivalent Flu Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Quadrivalent Flu Vaccine Sales 2020-2025 (K Doses)
Figure 39. Middle East & Africa Quadrivalent Flu Vaccine Revenue 2020-2025 ($ millions)
Figure 40. Americas Quadrivalent Flu Vaccine Sales Market Share by Country in 2025
Figure 41. Americas Quadrivalent Flu Vaccine Revenue Market Share by Country (2020-2025)
Figure 42. Americas Quadrivalent Flu Vaccine Sales Market Share by Type (2020-2025)
Figure 43. Americas Quadrivalent Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 44. United States Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Quadrivalent Flu Vaccine Sales Market Share by Region in 2025
Figure 49. APAC Quadrivalent Flu Vaccine Revenue Market Share by Region (2020-2025)
Figure 50. APAC Quadrivalent Flu Vaccine Sales Market Share by Type (2020-2025)
Figure 51. APAC Quadrivalent Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 52. China Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. India Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Quadrivalent Flu Vaccine Sales Market Share by Country in 2025
Figure 60. Europe Quadrivalent Flu Vaccine Revenue Market Share by Country (2020-2025)
Figure 61. Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2020-2025)
Figure 62. Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 63. Germany Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. France Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 71. Egypt Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Quadrivalent Flu Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Quadrivalent Flu Vaccine in 2025
Figure 77. Manufacturing Process Analysis of Quadrivalent Flu Vaccine
Figure 78. Industry Chain Structure of Quadrivalent Flu Vaccine
Figure 79. Channels of Distribution
Figure 80. Global Quadrivalent Flu Vaccine Sales Market Forecast by Region (2026-2031)
Figure 81. Global Quadrivalent Flu Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Quadrivalent Flu Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Quadrivalent Flu Vaccine Revenue Market Share Forecast by Application (2026-2031)